Company Number: 13112379

Analysis Date: 2025-07-20 12:16 UTC

1. Credit Opinion: DECLINE
   Pharmacy Professional Limited currently operates as a micro-entity with minimal financial activity and extremely limited capital (£30 share capital). The financial statements indicate no employees and no operational scale, with assets and net current assets standing at merely £30 for the last two reported years. There is no evidence of revenue generation or profits, and the company is essentially a shell with no discernible trading history. This profile carries a high credit risk as there is no demonstrated capacity to service debt or meet commercial obligations.

2. Financial Strength:
   The company's balance sheet is nominal, showing only £30 in current assets and shareholders' funds, with no fixed assets or liabilities reported. Net current assets and total assets less current liabilities are identical and negligible. The absence of working capital, retained earnings, or any profit reserves indicates zero financial strength and no cushion against financial stress. The micro-entity status and lack of operational scale suggest the company is in an embryonic or dormant phase rather than an active trading business.

3. Cash Flow Assessment:
   Given that current assets are only £30 with no further detail on cash or receivables, liquidity is effectively non-existent. There is no indication of operating cash flow, and the company employs no staff, implying no business activity generating cash inflows. Working capital is minimal and unable to support any meaningful operations or debt servicing. The lack of cash flow history or projections raises concerns over the company's ability to meet short-term obligations.

4. Monitoring Points:

• Watch for any filing of more detailed financial statements indicating business commencement or growth.
• Monitor for accumulation of working capital or revenue generation in future accounts.
• Track director changes or PSC updates that may signal restructuring or capital injections.
• Observe any overdue filings or regulatory issues that could indicate operational or financial distress.